Finance

Lists
Why is 300683 down 2,94%?
Dive Deeper
300683:SHE
Wuhan Hiteck Biological Pharma Co Ltd
23,80 CN¥
-2,94%
(-0,72) 1D
16 қаз., 15:04:58 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300683...
Open
24,86 CN¥
High
25,68 CN¥
Low
23,62 CN¥
Mkt. cap
3,21 млрд
Avg. vol.
6,29 млн
Volume
9,01 млн
52-wk high
50,68 CN¥
52-wk low
22,37 CN¥
EPS
-2,07 CN¥
Shares outstanding
130,89 млн
No. of employees
958
Open
24,86 CN¥
High
25,68 CN¥
Low
23,62 CN¥
Mkt. cap
3,21 млрд
Avg. vol.
6,29 млн
Volume
9,01 млн
52-wk high
50,68 CN¥
52-wk low
22,37 CN¥
EPS
-2,07 CN¥
Shares outstanding
130,89 млн
No. of employees
958
News stories
From web sources and news partners
About Wuhan Hiteck Biological Pharma Co Ltd
CEO-
Employees958
Founded1992 ж. 08 сәу.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
146,84 млн
119,55 млн
159,05 млн
66,47 млн
Cost of goods sold
79,88 млн
78,74 млн
97,87 млн
53,09 млн
Cost of revenue
79,88 млн
78,74 млн
97,87 млн
53,09 млн
Research and development expenses
19,60 млн
21,91 млн
19,43 млн
19,95 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
75,67 млн
72,55 млн
60,07 млн
56,77 млн
Operating expense
83,83 млн
115,96 млн
77,22 млн
84,95 млн
Total operating expenses
163,70 млн
194,71 млн
175,09 млн
138,04 млн
Operating income
-16,87 млн
-75,16 млн
-16,05 млн
-71,57 млн
Other non operating income
-3,02 млн
3,36 млн
-103,60 м.
114,73 м.
EBT including unusual items
-127,52 млн
-66,89 млн
-26,83 млн
-60,40 млн
EBT excluding unusual items
-18,53 млн
-62,83 млн
-15,50 млн
-70,17 млн
Income tax expense
-6,84 млн
7,65 млн
-2,90 млн
-4,44 млн
Effective tax rate
5,36%
-11,44%
10,81%
7,35%
Other operating expenses
-6,81 млн
10,42 млн
-904,39 м.
4,52 млн
Net income
-118,91 млн
-73,17 млн
-23,05 млн
-55,66 млн
Net profit margin
-80,98%
-61,21%
-14,49%
-83,74%
Earnings per share
-
-
-
-
Interest and investment income
1,71 млн
9,29 млн
920,58 м.
1,56 млн
Interest expense
-322,55 м.
-319,50 м.
-266,56 м.
-258,59 м.
Net interest expenses
1,39 млн
8,97 млн
654,02 м.
1,30 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
4,85 млн
-51,87 млн
7,24 млн
-49,78 млн
Gain or loss from assets sale
-572,00
979,18 м.
-
2,30 млн
AI content may include mistakes. Learn more
Google қолданбалары